Andre Tadic
Department of Psychiatry and Psychotherapy
University Medical Centre Mainz
Germany
Name/email consistency: high
- The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Tadić, A., Wagner, S., Schlicht, K.F., Peetz, D., Borysenko, L., Dreimüller, N., Hiemke, C., Lieb, K. Prog. Neuropsychopharmacol. Biol. Psychiatry (2011)
- Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder. Tadić, A., Elsässer, A., Storm, N., Baade, U., Wagner, S., Başkaya, O., Lieb, K., Dahmen, N. World J. Biol. Psychiatry (2010)
- Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial. Tadić, A., Gorbulev, S., Dahmen, N., Hiemke, C., Braus, D.F., Röschke, J., van Calker, D., Wachtlin, D., Kronfeld, K., Gorbauch, T., Seibert-Grafe, M., Lieb, K. Trials (2010)
- Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. Tadić, A., Helmreich, I., Mergl, R., Hautzinger, M., Kohnen, R., Henkel, V., Hegerl, U. J. Affect. Disord (2010)
- Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder. Tadić, A., Victor, A., Başkaya, O., von Cube, R., Hoch, J., Kouti, I., Anicker, N.J., Höppner, W., Lieb, K., Dahmen, N. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2009)
- Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in Borderline personality disorder. Tadić, A., Elsässer, A., Victor, A., von Cube, R., Başkaya, O., Wagner, S., Lieb, K., Höppner, W., Dahmen, N. J. Neural. Transm (2009)
- Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Tadić, A., Wagner, S., Hoch, J., Başkaya, O., von Cube, R., Skaletz, C., Lieb, K., Dahmen, N. Psychopathology (2009)
- Association analysis of SCN9A gene variants with borderline personality disorder. Tadić, A., Baskaya, O., Victor, A., Lieb, K., Höppner, W., Dahmen, N. J. Psychiatr. Res (2008)
- A monoamine oxidase B gene variant and short-term antidepressant treatment response. Tadić, A., Rujescu, D., Müller, M.J., Kohnen, R., Stassen, H.H., Dahmen, N., Szegedi, A. Prog. Neuropsychopharmacol. Biol. Psychiatry (2007)
- The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Tadić, A., Müller, M.J., Rujescu, D., Kohnen, R., Stassen, H.H., Dahmen, N., Szegedi, A. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2007)
- Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens. Tadic, A., Dahmen, N., Szegedi, A., Rujescu, D., Giegling, I., Koller, G., Anghelescu, I., Fehr, C., Klawe, C., Preuss, U.W., Sander, T., Toliat, M.R., Singer, P., Bondy, B., Soyka, M. Eur. Arch. Psychiatry. Clin. Neurosci (2005)
